Filing Flows › OptimizeRx (OPRX) › Q3 2025
OptimizeRx (OPRX) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 7, 2025
OptimizeRx (OPRX) reported revenue of $26.1M for the third quarter 2025 (Q3 2025), +22% from a year earlier and -11% from the quarter before. Operating margin was 7.9%, net earnings $779K (3.0% of revenue).
OptimizeRx, Q3 2025: revenue $26.1M (+22% year over year), operating margin 7.9%, net earnings $779K, operating cash flow $3.2M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $26.1M | -11% | +22% |
| Gross profit | $17.5M | -6% | +30% |
| Operating profit | $2.0M | -36% | — |
| Net earnings | $779K | -49% | — |
| Operating cash flow | $3.2M | -30% | +79% |
| Free cash flow | $3.2M | -30% | +80% |
What changed
Revenue was $26.1M in Q3 2025, up 22% year over year and down 11% from the previous quarter.
Gross margin was 67.2%, up 4.1 points from a year earlier. Operating profit was $2.0M, a 7.9% margin (up 48.0 points year over year). Operating expenses fell 30% while revenue rose 22%. Net earnings were $779K. The effective tax rate was 25.7%.
Operating cash flow was $3.2M (up 79% year over year), 411% of net earnings. Non-cash charges added back $1.1M of depreciation and amortization and $2.0M of share-based compensation. Working capital and other items used $613K. Capital expenditures of $10K left free cash flow of $3.2M.
Questions
What was OptimizeRx's revenue in the third quarter 2025?
OptimizeRx (OPRX) reported revenue of $26.1M for the third quarter 2025 (Q3 2025), +22% from a year earlier and -11% from the quarter before.
Was OptimizeRx profitable in the third quarter 2025?
Operating profit was $2.0M (7.9% of revenue) and net earnings $779K.
Source: OptimizeRx 10-Q on SEC EDGAR.